ReviewCurrent oncology (Toronto, Ont.)2023
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean.
Review in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- National Coordinated Care and Translational Research Program for Uveal Melanoma Pilot: Infrastructure, Biobanking, and Challenges in Liquid Biopsy Implementation in a Latin American Country.Ocular oncology and pathology · 2026Article
- The changing landscape of oncology clinical trials in Latin America.Nature reviews. Clinical oncology · 2026Article
- Article
- Oncology Education in Latin America: A Systematic Review of Curricular Gaps, Teaching Strategies, and Regional Initiatives.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Review
- Disparities in cancer clinical trials among low- and middle-income countries: A 20-year analysis.Cancer · 2025Article
- Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality.Journal of clinical medicine · 2025Article
- A call to strengthen clinical trials capacity in resource-limited settings.BMJ global health · 2025Article
- Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping.International journal of environmental research and public health · 2025Review
- Economic Benefits of Sponsored Clinical Trials in Cancer for the Colombian Healthcare System: A Real-World Evidence Approach.Cancer medicine · 2025Article
- Main challenges to cancer care in Latin America: an analysis through breast cancer lenses.Lancet regional health. Americas · 2025Review
- The state of cancer research and its association with the cancer burden in Ecuador: a bibliometric study.Discover oncology · 2025Article
- Strengthening Collaborations in Latin America for Advancing Oral cancer research and public health policies.Journal of clinical and experimental dentistry · 2025Review
- Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers.ESMO open · 2024Review
- Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis.JCO global oncology · 2024Article
- Global Equity in Clinical Trials: An ASCO Policy Statement.JCO global oncology · 2024Article
- Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group.Lancet regional health. Americas · 2024Review
- Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.Ecancermedicalscience · 2024Article
- Implementing precision oncology in Latin America to improve patient outcomes: the status quo and a call to action for key stakeholders and decision-makers.Ecancermedicalscience · 2024Article
- Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.Frontiers in oncology · 2023Article
- Current scenario and future perspectives of clinical research in Brazil: a national survey.Ecancermedicalscience · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Latin America and the Caribbean (LAC), progress has been made in some national and regional cancer control initiatives, which have proved useful in reducing diagnostic and treatment initiation delays. However, there are still significant gaps, including a lack of oncology clinical trials. In this article, we will introduce the current status of the region's clinical research in cancer, with a special focus on academic cancer research groups and investigator-initiated research (IIR) initiatives. Investigators in LAC have strived to improve cancer research despite drawbacks and difficulties in funding, regulatory timelines, and a skilled workforce. Progress has been observed in the representation of this region in clinical trial development and conduct, as well as in scientific productivity. However, most oncology trials in the region have been sponsored by pharmaceutical companies, highlighting the need for increased funding from governments and private foundations. Improvements in obtaining and/or strengthening the LAC cancer research group's financing will provide opportunities to address cancer therapies and management shortcomings specific to the region. Furthermore, by including this large, ethnic, and genetically diverse population in the world's research agenda, one may bridge the gap in knowledge regarding the applicability of results of clinical trials now mainly conducted in populations from the Northern Hemisphere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.